During the past decade, Pineo Medical Ecosystem conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pineo Medical Ecosystem" #1 sponsor was "H. Lundbeck A/S" with 4 trials, followed by "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "UroGen Pharma Ltd." with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pineo Medical Ecosystem" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "Clinical Accelerator (CRO)" with 1 trials as a collaborator, "Israeli-Georgian Medical Research Clinic Helsicore" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Pineo Medical Ecosystem" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Pineo Medical Ecosystem" are "Migraine" (3 trials), "Bladder Cancer" (2 trials), "Hypertension" (2 trials), "Multiple Sclerosis" (2 trials) and "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials). Many other conditions were trialed in "Pineo Medical Ecosystem" in a lesser frequency.

Most popular intervention types in "Pineo Medical Ecosystem" are "Drug" (13 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Eptinezumab" (4 trials), "Pimavanserin" (2 trials), "UGN-102" (2 trials) and "Data Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pineo Medical Ecosystem" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Pineo Medical Ecosystem". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Pineo Medical Ecosystem, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pineo Medical Ecosystem, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".